je.st
news
U.S. FDA panel: data support safety, efficacy of Merck allergy drug
2014-01-28 23:10:31| Biotech - Topix.net
Merck & Co's experimental allergy drug, Ragwitek, appears safe and effective for use in patients between the ages of 18 and 65, a panel of advisors to the U.S. Food and Drug Administration concluded on Tuesday.
Tags: support
data
safety
panel
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||